Summit Therapeutics (SMMT) Times Interest Earned (2020 - 2024)
Summit Therapeutics (SMMT) posted Times Interest Earned of -$8.98 for Q4 2024, up 62.23% on a QoQ basis from -$23.78 in Q3 2024, and up 27.1% year-over-year from -$7.07 in Q1 2024.
Summit Therapeutics (SMMT) Times Interest Earned (2020 - 2024) Analysis & Trends
Summit Therapeutics' Times Interest Earned history runs 5 years deep, the most recent figure standing at -$8.98 for Q4 2024.
- Quarterly Times Interest Earned rose 27.1% year-over-year to -$8.98 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$14.14 (up 59.01% YoY) and the FY2024 annual result came in at -$0.13, up 98.13% from the prior year.
- Times Interest Earned was -$8.98 for Q4 2024 at Summit Therapeutics, up from -$23.78 in the prior quarter.
- Across five years, Times Interest Earned topped out at $13023.5 in Q4 2021 and bottomed at -$626.78 in Q1 2021.
- A 5-year average of $750.6 and a median of -$16.4 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2021 — Times Interest Earned soared 3294179.97% — and 2024, when it slumped 324.44%.
- Summit Therapeutics' Times Interest Earned stood at -$0.4 in 2020, then surged by 3294179.97% to $13023.5 in 2021, then sank by 100.19% to -$24.48 in 2022, then jumped by 49.67% to -$12.32 in 2023, then grew by 27.1% to -$8.98 in 2024.
- Business Quant data shows SMMT's Times Interest Earned at -$8.98 in Q4 2024, -$23.78 in Q3 2024, and -$19.22 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Summit Therapeutics | 10.60 Bn | 10.00 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -8.98 |
| Sep 30, 2024 | -23.78 |
| Jun 30, 2024 | -19.22 |
| Mar 31, 2024 | -13.58 |
| Dec 31, 2023 | -12.32 |
| Sep 30, 2023 | -7.03 |
| Jun 30, 2023 | -4.53 |
| Mar 31, 2023 | -64.51 |
| Sep 30, 2022 | -24.48 |
| Jun 30, 2022 | -19.44 |
| Mar 31, 2022 | -74.61 |
| Dec 31, 2021 | 13,023.50 |
| Jun 30, 2021 | -109.86 |
| Mar 31, 2021 | -626.78 |
| Dec 31, 2020 | -0.40 |
| Sep 30, 2020 | -4.46 |